Risperidone and behavioral therapy in treatment of children and adolescents with autistic disorder

Trial Profile

Risperidone and behavioral therapy in treatment of children and adolescents with autistic disorder

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2015

At a glance

  • Drugs Risperidone (Primary)
  • Indications Autistic disorder; Pervasive child development disorders
  • Focus Therapeutic Use
  • Acronyms RUPP PI PDD
  • Most Recent Events

    • 15 Aug 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.
    • 06 Dec 2007 Status changed from in progress to completed.
    • 13 Jun 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top